User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Dec 17 2014 14:01 IST RSS 2.0
 
1 to 20 of 2,706    
Novartis moves court seeking to restrain Cipla from selling respiratory drug Onbrez 17.12.2014 ET: Pharma
Experts say that the MNC's stand is a clear violation of IP laws, which stipulate that the patent has to be 'locally worked' — that is, be affordable.
Also found in: [+]
Novartis drags Cipla to court 17.12.2014 TOI: India Business
Drug MNC Novartis has moved the Delhi high court seeking to restrain generic firm Cipla from selling an affordable version of its respiratory drug Onbrez in the domestic market.
Also found in: [+]
Qualcomm probe: US presses China on antitrust policy 16.12.2014 TOI: All Headlines
Qualcomm probe: US presses China on antitrust policy
Also found in: [+]
SC to review ex-judge’s verdict helping sister 16.12.2014 TOI: India
SC on Monday decided to take a fresh look at one of its judgments delivered earlier this year by a bench headed by Justice H L Gokhale just prior to his retirement, which allegedly helped his ...
Also found in: [+]
India-led BRICS opposes UN arm’s move on model drug law 15.12.2014 ET: Policy
UNODC had last week held closed-door meetings in Vienna to firm up a model law prescribing harsh penalties for ‘falsified’ drug-related crimes.
Also found in: [+]
Government may not act on Cipla’s patent plea 15.12.2014 TOI: India Business
In a setback to Cipla, the homegrown generics medicine company, the government has so far found little merit in its plea for waiver and cancellation of patent rights for five drugs over which Novartis has exclusive rights.
Also found in: [+]
Xiaomi assessing legal options 14.12.2014 The Hindu: Today's Paper
Xiaomi assessing legal options
Also found in: [+]
Let India make cheap drugs 14.12.2014 Sify Finance
Last month, the United States and India announced an important breakthrough concerning India's "right-to-food" programme. The Indian government subsidises food for its poorest citizens
Also found in: [+]
India court blocks Bayer generic drug appeal 14.12.2014 Hindustan Times: Business
Anbspcourt has rejected German drug giant Bayers bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker a move hailed by activists on ...
Also found in: [+]
Let India make cheap drugs 13.12.2014 Features
Our officials should be supporting India's medicinal patent policies, even if it means standing up to corporate lobbies at home
Also found in: [+]
Forced to suspend sales, Xiaomi assessing legal options 13.12.2014 Hindu: Technology
Forced to suspend sales of its devices in India post directions of the Delhi High Court, Chinese smartphone maker Xiaomi has said it is “assessing legal options” to continue operations. ...
Also found in: [+]
SC Dismisses SLP Filed by Bayer against Natco 13.12.2014 newindianexpress.com
Also found in: [+]
Let India make cheap drugs, says America 12.12.2014 Deccan Herald - Analysis
Last month, the United States and India announced an important breakthrough concerning India's "right-to-food" programme. The Indian government subsidises food for its poorest citizens through a system of price supports and public stockpiling. The programme is critical to India's future. According to the Unicef, one in three of the world's malnourished children lives in India. But as India's policy has expanded, it has come into conflict with World Trade Organisation rules on agriculture. The conflict heated up last summer when India demanded an explicit assurance at the WTO that it could maintain its right-to-food programme. The United States resisted, and the standoff derailed the first new global trade agreement at the WTO since the 1990s. The impasse now seems to be resolved; with American support, India has secured a "peace clause" at the WTO that protects its food programme from legal challenges. As India insisted, the deal applies indefinitely, until a permanent solution to the conflict is found, ...
Also found in: [+]
Xiaomi switches off India phone sales 12.12.2014 Deccan Herald - Business
Chinese smartphone maker Xiaomi, which became a rage in India in recent times with sale of its feature-rich, yet affordable devices, has temporarily suspended sales in the country after the Delhi High Court, in an interim order has directed the company as well as Flipkart to stop selling its products in India, following a patent dispute. The temporary ban which will extend until February 5, is the result of a patent infringement case that Swedish telecom equipment maker Ericsson filed against Xiaomi in India. Ericsson confirmed that it is taking legal action against Xiaomi in India for using its technology in smartphone devices without paying licensing fee. The unexpected ban comes just five months after Xiaomi's entry into the world's third largest smartphone market where it retails smartphones, Redmi 1S and Redmi Note on e-commerce site Flipkart. Ericsson is demanding that the smartphone maker compensate it for using protected technology in its phones in India. Following the ban, Xiaomi Vice-President ...
Also found in: [+]
Protecting patents will boost innovation in India 12.12.2014 HBL: Features
This is also essential to meet the healthcare challenges facing the country
Also found in: [+]
Delhi High Court orders Xiaomi to stop importing, selling smartphones in India: Report 10.12.2014 DNA: Top News
This past week we have seen a lot of bans being imposed on companies, and after the likes of Uber and similar app-based cab services, now it is Xiaomi that is in the crosshairs. The Delhi High Court has passed an interim injunction that stops the Chinese smartphone company from importing, selling or advertising its devices in India, Medianama reports. Xiaomi’s Manu Jain has responded to BGR India 's email saying- We haven’t received an official notice from the Delhi High Court. However, our legal team is currently evaluating the situation based on the information we have. India is a very important market for Xiaomi and we will respond promptly as needed and in full compliance with Indian laws. Moreover, we are open to working with Ericsson to resolve this matter amicably. The injunction is related to the case involving Ericsson’s standard essential patents (SEP). The court says that the decision was taken after Xiaomi failed to reply to Ericsson’s repeated communications. The former smartphone maker is ...
Also found in: [+]
UN Office on Drugs and Crime scheduled to meet to firm up model law 8.12.2014 ET: Pharma
India is not part of the UNODC expert group, but as one of the largest generic drugs suppliers, its supply chain may face direct consequences.
Also found in: [+]
Steve Jobs is star witness in Apple suit 1.12.2014 TOI: Home
Three years after his death, Steve Jobs is very much a presence in courtrooms across United States.
Also found in: [+]
Panel to draft intellectual property policy riddled with conflict of interest 1.12.2014 TOI: India
Increased focus on India’s intellectual property and patent law has put the spotlight on the IP think tank set up by the Department of Industrial Policy and Promotion (DIPP). It is a six-member panel with zero representation from independent academicians working on the subject and none from civil society groups working on public interest ramifications of intellectual property ...
Also found in: [+]
If US had a patent law like ours, they would discover many more drugs: Anand Grover 30.11.2014 ET: Opinion
'Make in India' should be made in India by Indians for Indians and for the whole of humanity. It should not become Make in India by foreigners, where India by foreigners, where they take over our industries.
Also found in: [+]
1 to 20 of 2,706